Objectives: We retrospectively compared and quantified magnetic resonance (MR) images to distinguish major histological types of uterine sarcomas and malignant and benign tumors.
Introduction
Uterine sarcomas are rare tumors, with an annual incidence of 1.7 per 100,000 females, and they constitute about 10% of all malignancies of the uter-ine body. 1, 2 The major histological types are leiomyosarcomas (38 to 46% of uterine sarcomas), carcinosarcomas (27 to 48%), and endometrial stromal sarcomas (10 to 15%). [1] [2] [3] Sarcomas are the most devastating uterine malignancies, characterized by aggressive behavior, rapid growth, and a high rate of dissemination. Five-year survival rates are 19 to 41% for leiomyosarcomas, 21 to 62% for carcinosarcomas, and 45 to 61% for endometrial stromal sarcomas. 4 -7 The prognosis of leiomyosarcomas tends to worsen with age, higher tumor grade and stage, and lack of primary surgical treatment. 8 Carcinosarcomas are highly aggressive tumors with worse prognoses than ordinary endometrial carcinomas. 9 Early stage and low grade endometrial stromal sarcomas have a 97% survival rate but require long-term follow-up because of their characteristic late recurrences. 7, 9 Standardized treatments for uterine sarcomas have not been established, and treatments differ according to the histological subtype. [7] [8] [9] [10] Because of these diagnostic, prognostic, and therapeutic differences, magnetic resonance (MR) imaging becomes an important tool for the initial diagnosis of uterine sarcoma. Several studies have presented MR findings of uterine sarcoma, but diagnosing and distinguishing specific sarcoma groups have been difficult because of the variability of their malignant components, including hemorrhage and necrosis.
We believe no study has assessed and compared the MR features of each uterine sarcoma group. Accordingly, we attempted to distinguish the major histological types of uterine sarcomas and malignant and benign tumors through a retrospective comparison and quantification of MR images.
Materials and Methods

Patients
An institutional review board approved this retrospective study and waived informed consent. We selected the clinical records and MR images of 25 pathologically confirmed uterine sarcomas (8 leiomyosarcomas, 11 carcinosarcomas, 6 endometrial stromal sarcomas) from patients who underwent preoperative MR examinations between January 1 2001 and September 30 2010. The median duration between MR imaging and surgery was 33 days (range, 20 to 52 days). Patients were interviewed to ascertain clinical characteristics that included age, menopausal status, symptoms, pregnancy, childbirth history, medical history, medication history, and presence of infectious diseases. One patient with carcinosarcoma and one with endometrial stromal sarcoma received gonadotropin-releasing hormone analogue treatment before surgery, and a patient with leiomyosarcoma received tamoxifen therapy after breast cancer surgery. Another patient with carcinosarcoma was an atomic-bomb survivor. We also reviewed 25 pathologically confirmed uterine leiomyomas, excluding variants such as red degeneration or lipoleiomyoma, for comparison with uterine sarcomas. We randomly selected patients with uterine leiomyoma from the same period as the patients with uterine sarcoma, eight of whom received gonadotropin-releasing hormone analogue treatment before surgery.
MR imaging techniques
MR imaging was performed with one of three 1. 
Image analysis of MR findings
Two radiologists retrospectively and independently interpreted MR images by consensus. When there were multiple tumors in the uterus, the largest tumor was assessed.
MR findings were assessed by tumor size (greatest diameter), location (myometrium, endometrial cavity, or subserous region), contour (smooth or irregular), presence or absence of hemorrhage, and presence of necrotic and cystic components (areas of high signal intensity [SI] on T 2 -weighted images without enhancement on contrast-enhanced T 1 -weighted images).
The present study focused on the contrast ratio (CR) of SI on T 2 -weighted images, defined as:
We placed regions of interest (ROI) for the SI of the tumor (SI tumor ) on the areas of lowest, highest, and main SI (Fig. 1 ) and calculated the CR of each region 3 times obtain an average. The main SI was defined as the SI occupying the majority of the tumor. Hemorrhagic parts, necrotic and cystic parts, and calcifications were excluded from measurement. The SI of the iliopsoas muscle (SI iliopsoas muscle ) was also measured, but the SI of the uterine myometrium was not used in this formula because SIs in the uterine myometrium on T 2 -weighted images varied depending on the patient's menstrual cycle. 11 The CR was calculated for each of the 3 areas of SI.
To quantify the heterogeneity of gadolinium-enhanced tumors, we also calculated the contrast-enhanced ratio (CER) of the main solid part to the whole solid part of the tumor following gadolinium enhancement on T 1 -weighted images using the formula:
CER ¼ jSI main solid part À SI whole solid part j =SI whole solid part :
When the SI of the main solid part (SI main solid part ) and the SI of the whole solid part (SI whole solid part ) represented similar values, the CER absolute value was approximated to 0, which was considered to represent tumors with more homogeneous gadolinium enhancement. In contrast, when the SI main solid part and the SI whole solid part represented markedly different values, the CER absolute value was approximated to one, which was considered to represent tumors with more heterogeneous enhancement. To eliminate the effects of intratumoral hemorrhagic, necrotic, and cystic changes so far as possible, the ROI of the SI whole solid part was strictly measured as the enhanced area of the tumor. The SI main solid part was measured as the area of main SI on T 2 -weighted images in the largest cut slice of the tumor (Fig. 2) .
We assessed DW images and ADC values in 4 sarcomas and 14 leiomyomas, grading signal intensity on DW images as high, slightly high, or iso to low compared to that of the iliopsoas muscle 12 and measuring ADC values for each tumor in ROIs placed on ADC maps at a workstation to exclude hemorrhagic and cystic components.
Histopathologic analysis
All specimens were obtained from surgical resection of lesions, stained with hematoxylin-eosin, and examined by 2 experienced pathologists blinded to the MR results. The histopathologic specimens were evaluated to confirm diagnoses of uterine sarcoma and classified as 8 leiomyosarcomas, 11 carcinosarcomas, 6 endometrial stromal sarcomas, and 25 leiomyomas. Leiomyosarcomas included one diagnosis of myxoid leiomyosarcoma. Endometrial stromal sarcomas were subdivided into 5 low and one high grade type defined as endometrial sarcoma 9 but were evaluated as one category (i.e., endometrial stromal tumor) because of the study's small sample size. Carcinosarcomas were subdivided into 8 homogeneous and 3 heterogeneous types. Four of 25 leiomyomas had hyaline degenerations.
Statistical analysis
Normally distributed data are described as mean « standard deviation, with skewed data summarized using the median (interquartile range). Comparisons of MR findings and clinical parameters between uterine sarcomas and leiomyomas were performed using Mann-Whitney's U test for continuous variables and » 2 test for categorical variables. Comparisons among leiomyosarcomas, carcinosarcomas, and endometrial stromal sarcomas were performed with the Kruskal-Wallis test and » 2 test. For multiple comparisons, analyses were performed with Mann-Whitney's U test modified with Bonferroni criterion. The relationship between tumor characteristics and size was evaluated with Mann-Whitney's U test. We analyzed statistics using Dr. SPSS II software for Windows (Release 11.0.1J, SPSS, Inc., Chicago, IL, USA). A P value less than 0.05 was considered to be statistically sig- Fig. 1c ). Contrast-enhanced T 1 -weighted image shows the tumor with entirely homogeneous enhancement. The CER was less than 0.01.
nificant.
Results Table 1 summarizes the clinical features of the various histological types of uterine sarcoma and leiomyoma. Menopausal status and symptoms did not differ significantly between sarcoma groups. Table 2 summarizes comparisons between uterine sarcomas and leiomyomas. Significant differences were found in tumor location, contour, and presence of hemorrhagic, necrotic, and cystic components. Most leiomyomas had smooth contours, whereas hemorrhages or necrotic and cystic components were frequently found in uterine sarcomas. Quantitative assessment revealed significantly higher CR for the area of lowest SI (1.36 « 1.58, P < 0.05) and the area of main SI (2.54 « 2.12, P < 0.01) in sarcomas than leiomyomas. Further, the CER showed significantly more heterogeneous enhancement in sarcomas than leiomyomas (0.12 « 0.14, P < 0.05).
All 4 cases of uterine sarcoma showed high SI on DW images. Among leiomyomas, 6 cases showed slightly high intensity, and the other 8 cases showed iso to low SI on DW images. The mean ADC value (10 ¹3 mm 2 /s) of sarcomas (1.14 « 0.34) was lower than that of leiomyomas (1.43 « 0.20), though the difference was not significant. In 4 sarcoma cases, the mean ADC value was 1.65 in a myxoid leiomyosarcoma, 0.96 in a serous adenocarcinoma with endometrial sarcoma component, 0.94 in an endometrioid adenocarcinoma with leiomyosarcoma component, and 1.01 in an endometrial stromal sarcoma of low grade type. Table 3 summarizes characteristics from the MR findings of uterine sarcomas. Patients with endometrial stromal sarcomas were significantly younger than patients from the other groups, and leiomyosarcoma tumors were larger than other sarcoma types. Leiomyosarcomas were located mainly in the myometrium, whereas carcinosarcomas were located in the endometrial cavity.
The CR for the area of lowest SI on T 2 -weighted images was significantly lower in leiomyosarcomas than other sarcomas (0.31 « 0.39, P < 0.05, Figs.  1, 3a) . Although the CRs for the areas of main and highest SI tended to increase in the order of leiomyosarcoma to carcinosarcoma to endometrial stromal sarcoma, the differences were not significant (Figs. 1, 3b, 3c) . The CER for endometrial stromal sarcomas showed the most significant homogeneous enhancement compared to the other 2 sarcoma groups (0.02 « 0.02, P < 0.05, Figs. 2,  3d ). Figure 4 shows relationships between the CR for the area of lowest SI and the CER for each uterine sarcoma. Scatter plots using a combination of these 2 parameters avoided overlap between leiomyosarcomas and endometrial stromal sarcomas, but the plots of carcinosarcomas showed considerable overlap with the other groups. Table 4 summarizes the relationship between tumor characteristics and the size of uterine sarcomas. Hemorrhagic or necrotic and cystic components were found more often in larger tumors, although there was no significant difference in their occurrence among the 3 sarcoma groups (Table 3) . These components were found in all leiomyosarco- mas and endometrial stromal sarcomas and nearly half of all carcinosarcoma cases; in particular, 6 of 8 leiomyosarcomas and 3 of 6 endometrial stromal sarcomas had a mass greater than 10 cm in diameter.
Discussion
Several studies have reported the MR features for each type of uterine sarcoma, but comparisons between the histological types have not been performed. Our study found that quantitative assessment of the CR on T 2 -weighted images and the CER on contrast-enhanced T 1 -weighted images revealed characteristic findings in leiomyosarcomas and endometrial stromal sarcomas. The CR and CER were also useful in differentiating uterine sarcomas from benign leiomyomas. Namimoto and associates 13 reported the significantly higher tumormyometrium contrast ratio on T 2 -weighted images of uterine sarcomas than leiomyoma, and Tanaka's group 14 reported the high SI on T 2 -weighted images of more than 70% of smooth muscle tumors of uncertain malignant potential and leiomyosarcomas compared with leiomyomas. Leiomyosarcomas are the most malignant smooth muscle tumors of the uterus, show the microscopic constellation of hypercellularity, severe nuclear atypia, and high mitotic rate, and rarely originate as a malignant counterpart of leiomyomas. 9 We observed the considerable overlap of the CR for the areas of highest SI on T 2 -weighted images, whereas the CR for the areas of lowest SI showed characteristic findings in leiomyosarcomas, which were thought to reflect their histological features.
Sahdev and colleagues 15 reported that most uterine sarcomas, including those of various subtypes, showed strong contrast enhancement. Tanaka's : » 2 test *One case was excluded from evaluation because no contrast-enhanced T 1 -weighted image had been taken. **Contrast-enhanced T 1 -weighted image was not obtained for one case. ***Diffusion-weighted images and apparent diffusion coefficient (ADC) values were evaluated in 4 sarcomas and 14 leiomyomas. CER, contrast-enhanced ratio of main solid part; n. s., not significant; SI, signal intensity group 14 reported that leiomyosarcomas had well demarcated and unenhanced areas and some unenhanced pocket-like areas and that carcinosarcomas had both unenhanced and strongly enhanced areas in the same tumor. 16 Ueda's group 17 described the greater enhancement of endometrial stromal sarcomas than the normal myometrium as a result of their hypervascularity. Classic histological characteristics of endometrial stromal sarcomas include a uniform band of small cells, which resembles proliferative phase endometrial stroma, and numerous thin-walled small arteriolar-type vessels. 3 The assessment of tumor heterogeneity in a contrast-enhanced study is important along with the assessment of tumor vascularity; nevertheless, no study has objectively assessed whether tumor enhancement is homogeneous or heterogeneous. The CER defined in this study enabled a quantitative assessment of the heterogeneity of gadolinium-enhanced tumors and objectively demonstrated the greater homogeneous enhancement of endometrial stromal sarcomas than other uterine sarcomas.
A scatter plot of the CR for the area of lowest SI and the CER in carcinosarcomas overlapped considerably with the other 2 groups, findings probably attributable to the histological variety of these tumors that generally comprise 2 or more different components. The classification of the World Health Organization designates these tumors as "carcinosarcomas," but the more commonly used term to describe them is "malignant mixed müllerian tumor (MMMT)." 3 Carcinosarcomas are composed of an admixture of malignant epithelial elements and sarcomatous elements. 3, 9 The sarcomatous elements can be homologous or heterologous. Homologous mesenchymal components usually consist of undifferentiated sarcomas, leiomyosarcomas, or endometrial stromal sarcomas, whereas heterologous mesenchymal elements typically consist of malignant cartilage or skeletal muscle in the form of rhabdomyoblasts. Carcinosarcomas commonly present as endometrial masses with heterogeneous hyper- 2 test *One case was excluded from evaluation because no contrast-enhanced T 1 -weighted image had been taken. **Contrast-enhanced T 1 -weighted image was not obtained for one case. CER, contrast-enhanced ratio of main solid part; n. s., not significant; SI, signal intensity intensity on T 2 -weighted images, 16, 18, 19 but they have been reported to have no specific MR findings because of various coexisting malignant components that include necroses and hemorrhages. In particular, small-sized carcinosarcomas are difficult to distinguish from endometrial carcinomas. 15, 18, 20 The presence of necrotic and hemorrhagic changes in this study were useful in differentiating uterine sarcomas from benign leiomyomas, but these changes were related to tumor size rather than histology. Although tumor size differed significantly among the 3 uterine sarcoma groups, neither necroses nor hemorrhagic changes were related to histological differentiation. On the other hand, there were statistical differences in tumor location among the uterine sarcoma groups. Uterine sarcomas commonly present as large heterogeneous masses, and necrotic and hemorrhagic changes are frequently found in the major subtypes. 15 Leiomyosarcomas commonly present as intramural to subserosal masses that replace the normal uterine architecture. 14, 15 Carcinosarcomas are typically endometrial polypoid masses that fill the uterine cavity and prolapse through the cervical os, frequently demonstrate myometrial invasion, and are often indistinguishable from endometrial carcinomas. 9, 15 Endometrial stromal sarcomas have variable forms, such as polypoid endometrial masses, intramyometrial masses, and diffuse myometrial Fig. 3 . Box plots indicate the contrast ratio (CR) for the area of lowest signal intensity (SI) (a), the CR for the area of main SI (b), the CR for the area of highest SI (c), and the contrast-enhanced ratio of the main solid part (CER) (d) among leiomyosarcomas (LMS), carcinosarcomas (CS), and endometrial stromal sarcomas (ESS). The line in each box represents the median, and the vertical error bars indicate minimum and maximum values. Analyses were performed using MannWhitney's U test with modified Bonferroni criterion for multiple comparisons. Significant differences in the CR for the area of lowest SI were observed between LMS and ESS (P < 0.05) and between LMS and CS (P < 0.05). No significant differences were observed in the CR for the areas of main and highest SI. A significant difference in the CER was observed between LMS and ESS (P < 0.05).
thickening, and show extrauterine pelvic extension that commonly involves the ovary. 9, 21 Our study suggested that tumor location might help in predicting the histological type of uterine sarcoma, but because histological type cannot be distinguished on the basis of tumor size, necrosis, or hemorrhagic change alone, a detailed assessment of MR imaging is needed.
On DW images, all 4 uterine sarcomas in this study showed high intensity, and 3 of the 4 tumors also showed low mean ADC values. The results in these 3 cases were similar to those of previous reports, 12, 13, 22 but the remaining case, a myxoid leiomyosarcoma, showed a high ADC value due to the myxoid component. Maeda and associates 23 reported significantly higher ADC values of myxoid-containing soft-tissue tumors than nonmyxoid soft-tissue tumors; furthermore, the myxoid matrix influenced the ADC values of both benign and malignant tumors. Tamai's team 22 reported the high SI of uterine sarcomas and cellular leiomyomas on DW images. They reported that the ADC value of uterine sarcomas was significantly lower than those of degenerated leiomyomas, whereas the ADC values of ordinary leiomyoma, cellular leiomyoma, and uterine sarcomas were overlapped. In the case of hyperintense uterine myometrial lesions on T 2 -weighted images, Takeuchi and colleagues 12 reported that it was difficult to differentiate uterine leiomyomas from malignant lesions using DW images alone. They reported that the ADC values of the solid part with lower SI on T 2 -weighted images were significantly lower in malignant tumors than those of benign leiomyomas including cellular leiomyomas and degenerated leiomyomas. Namimoto and associates 13 reported that uterine sarcomas and leiomyomas could be sufficiently distinguished by a combination of ADC values and the tumor-myometrium contrast ratio on T 2 -weighted images, and Kato's group 20 reported that the DW image and ADC mapping image clearly distinguished adenocarcinoma components from sarcoma components in one of 4 cases of carcinosarcoma. DW imaging with ADC values yields quantitative information that reflects tissue cellularity, 12, 22 so further assessment of uterine sarcomas with various histological components is required that includes DW imaging, ADC values, and histology.
This study has some limitations. Because it was retrospective and included only a small number of patients, further validation of our findings requires a prospective study with a substantially larger sample, and more comparisons are needed using MR images of leiomyomas with more variable degenerations to overcome the selection bias with the leiomyomas in this study.
In conclusion, the quantitative assessment of the CRs or CERs of tumors was useful in distinguishing the major histological types of uterine sarcomas and benign and malignant uterine tumors. When the solid parts of a tumor show homogeneous gadolinium enhancement in younger patients, endometrial stromal sarcoma should be considered. If areas of lower SI on T 2 -weighted images are observed in a large myometrial tumor with hemorrhage and irregular contours, leiomyosarcoma should be suspected. Leiomyomas of typical histological type showed lower SI on T 2 -weighted images and more homogeneous gadolinium enhancement compared to sarcomas. Moreover, the presence of hemorrhage, necrotic and cystic components, and irregular contours or unclear margins were useful for distinguishing malignant and benign tumors, but sarcoma groups do not always possess characteristic MR findings.
